Derayah Financial is offering 49.94 million shares, representing 20 per cent of the company’s total issued share capital.

DAM Capital said that for the first nine months of the year, it executed 17 transactions which raised a total of nearly ...

As per provisional closing data, the barometer index, the S&P BSE Sensex, declined 329.92 points or 0.43% to 76,190.46. The Nifty 50 index lost 113.15 points or 0.49% to 23,092.20. In two consecutive ...

IPO stocks are expected to see a bright year ahead this 2025, especially backed by the ongoing bull run at the US stock ...

The company, which operates more than 209 hospitals across India and Africa, intends to merge its listed subsidiary, Dr. Agarwals Eye Hospital, with the parent company through a share swap within the ...

Derayah got the Saudi market regulator Capital Market Authority’s nod in December for the sale of 49,947,039 ordinary shares, ...

The round saw participation from high-profile investors, including Tiger Global, Evolvence, Foundamental GmbH, Ashish Kacholia, Nikhil Kamath, Abhijit Pai, Sumeet Kanwar, Nuvama, and CapriGlobal.

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Capillary Technologies has restarted the preparations for its IPO and is likely to file the IPO papers for a $200 Mn public ...

Aardvark Therapeutics files for IPO. Company develops hunger-targeting obesity drug ARD-101 and ARD-201, led by CEO Tien Lee.

Fintech unicorn Groww is looking to file its DRHP with SEBI by April-May for an initial public offering (IPO) worth over $1 ...

When Donald Trump’s real estate business wanted to break into the Indian market in 2012, it turned to Atul Chordia and his ...